FLT3/D835Y-IN-1 is an orally available and selective inhibitor of FLT3 and FLT3/D835Y, with IC50 values of 0.26 nM and 0.18 nM, respectively; it suppresses tumor growth, exhibits anticancer activity, and can be used for the study of acute myeloid leukemia.